Literature DB >> 16282467

Murine gammaherpesvirus 68 infection is associated with lymphoproliferative disease and lymphoma in BALB beta2 microglobulin-deficient mice.

Vera L Tarakanova1, Felipe Suarez, Scott A Tibbetts, Meagan A Jacoby, Karen E Weck, Jay L Hess, Samuel H Speck, Herbert W Virgin.   

Abstract

Human gammaherpesvirus infections are associated with development of lymphoproliferative disease. Understanding of the mechanisms of gammaherpesvirus lymphomagenesis during chronic infection in a natural host has been limited by the exquisite species specificity of human gammaherpesviruses and the expense of primates. Murine gammaherpesvirus gammaHV68 is genetically and biologically related to human gammaherpesviruses and herpesvirus saimiri and has been reported to be associated with lymphoproliferative disease in mice (N. P. Sunil-Chandra, J. Arno, J. Fazakerley, and A. A. Nash, Am. J. Pathol. 145:818-826, 1994). We report the development of an animal model of gammaHV68 lymphomagenesis in BALB/c beta2 microglobulin-deficient mice (BALB beta2m-/-). GammaHV68 infection induced two lymphoproliferative lesions: B-cell lymphoma and atypical lymphoid hyperplasia (ALH). ALH lesion histology resembled lesions of Epstein-Barr virus-associated posttransplant lymphoproliferative disease and was characterized by the abnormal infiltration of the white pulp with cells expressing the plasma cell marker CD138. Lymphomas observed in gammaHV68-infected animals were B220+/CD3- large-cell lymphomas. GammaHV68-infected cells were common in ALH lesions as measured by in situ hybridization with a probe specific for viral tRNAs (vtRNAs), but they were scarce in gammaHV68-infected spleens with normal histology. Unlike ALH lesions, gammaHV68 vtRNA-positive cells were rare in lymphomas. GammaHV68 infection of BALB beta2m-/- mice results in lymphoproliferation and lymphoma, providing a valuable tool for identifying viral and host genes involved in gammaherpesvirus-associated malignancies. Our findings suggest that gammaHV68 induces lymphomas via hit-and-run oncogenesis, paracrine effects, or stimulation of chronic inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16282467      PMCID: PMC1287585          DOI: 10.1128/JVI.79.23.14668-14679.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  70 in total

1.  Kinetic and phenotypic changes in murine lymphocytes infected with murine gammaherpesvirus-68 in vitro.

Authors:  Bernadette M Dutia; James P Stewart; Robert A E Clayton; Heather Dyson; Anthony A Nash
Journal:  J Gen Virol       Date:  1999-10       Impact factor: 3.891

Review 2.  Gammaherpesviruses and "Hit-and-Run" oncogenesis.

Authors:  R F Ambinder
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

3.  Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy.

Authors:  I A Darenkov; M A Marcarelli; G P Basadonna; A L Friedman; K M Lorber; J G Howe; J Crouch; M J Bia; A S Kliger; M I Lorber
Journal:  Transplantation       Date:  1997-09-27       Impact factor: 4.939

4.  Murine gammaherpesvirus 68 encodes tRNA-like sequences which are expressed during latency.

Authors:  R J Bowden; J P Simas; A J Davis; S Efstathiou
Journal:  J Gen Virol       Date:  1997-07       Impact factor: 3.891

5.  Disappearance of the Epstein-Barr virus in a relapse of Hodgkin's disease.

Authors:  H J Delecluse; T Marafioti; M Hummel; F Dallenbach; I Anagnostopoulos; H Stein
Journal:  J Pathol       Date:  1997-08       Impact factor: 7.996

6.  Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen.

Authors:  G Gaidano; A Gloghini; V Gattei; M F Rossi; A M Cilia; C Godeas; M Degan; T Perin; V Canzonieri; D Aldinucci; G Saglio; A Carbone; A Pinto
Journal:  Blood       Date:  1997-12-15       Impact factor: 22.113

7.  Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease.

Authors:  K E Weck; A J Dal Canto; J D Gould; A K O'Guin; K A Roth; J E Saffitz; S H Speck; H W Virgin
Journal:  Nat Med       Date:  1997-12       Impact factor: 53.440

8.  G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.

Authors:  C Bais; B Santomasso; O Coso; L Arvanitakis; E G Raaka; J S Gutkind; A S Asch; E Cesarman; M C Gershengorn; E A Mesri; M C Gerhengorn
Journal:  Nature       Date:  1998-01-01       Impact factor: 49.962

Review 9.  NK cell recognition of non-classical HLA class I molecules.

Authors:  M López-Botet; M Llano; F Navarro; T Bellón
Journal:  Semin Immunol       Date:  2000-04       Impact factor: 11.130

10.  Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma.

Authors:  T Y Yang; S C Chen; M W Leach; D Manfra; B Homey; M Wiekowski; L Sullivan; C H Jenh; S K Narula; S W Chensue; S A Lira
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

View more
  73 in total

1.  Gammaherpesvirus gene expression and DNA synthesis are facilitated by viral protein kinase and histone variant H2AX.

Authors:  Bryan C Mounce; Fei Chin Tsan; Lindsay Droit; Sarah Kohler; Justin M Reitsma; Lisa A Cirillo; Vera L Tarakanova
Journal:  Virology       Date:  2011-09-22       Impact factor: 3.616

2.  CD4 T-cell help programs a change in CD8 T-cell function enabling effective long-term control of murine gammaherpesvirus 68: role of PD-1-PD-L1 interactions.

Authors:  Peter Dias; Francesca Giannoni; Lian Ni Lee; Dongun Han; Sorah Yoon; Hideo Yagita; Miyuki Azuma; Sally R Sarawar
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

3.  Strain-dependent requirement for IFN-γ for respiratory control and immunotherapy in murine gammaherpesvirus infection.

Authors:  Ching-Yi Tsai; Zhuting Hu; Weijun Zhang; Edward J Usherwood
Journal:  Viral Immunol       Date:  2011-08       Impact factor: 2.257

4.  B Cell-Intrinsic Expression of Interferon Regulatory Factor 1 Supports Chronic Murine Gammaherpesvirus 68 Infection.

Authors:  C N Jondle; K E Johnson; A A Uitenbroek; P A Sylvester; C Nguyen; W Cui; V L Tarakanova
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

5.  Gamma-herpesvirus kinase actively initiates a DNA damage response by inducing phosphorylation of H2AX to foster viral replication.

Authors:  Vera L Tarakanova; Van Leung-Pineda; Seungmin Hwang; Chiao-Wen Yang; Katie Matatall; Mickael Basson; Ren Sun; Helen Piwnica-Worms; Barry P Sleckman; Herbert W Virgin
Journal:  Cell Host Microbe       Date:  2007-06-14       Impact factor: 21.023

6.  NF-kappaB p50 plays distinct roles in the establishment and control of murine gammaherpesvirus 68 latency.

Authors:  Laurie T Krug; Christopher M Collins; Lisa M Gargano; Samuel H Speck
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

7.  The de novo methyltransferases DNMT3a and DNMT3b target the murine gammaherpesvirus immediate-early gene 50 promoter during establishment of latency.

Authors:  Kathleen S Gray; J Craig Forrest; Samuel H Speck
Journal:  J Virol       Date:  2010-03-03       Impact factor: 5.103

8.  LXR Alpha Restricts Gammaherpesvirus Reactivation from Latently Infected Peritoneal Cells.

Authors:  P T Lange; C N Jondle; E J Darrah; K E Johnson; V L Tarakanova
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

Review 9.  Connivance, Complicity, or Collusion? The Role of Noncoding RNAs in Promoting Gammaherpesvirus Tumorigenesis.

Authors:  Whitney L Bullard; Erik K Flemington; Rolf Renne; Scott A Tibbetts
Journal:  Trends Cancer       Date:  2018-10-10

10.  Infection and persistence of rhesus monkey rhadinovirus in immortalized B-cell lines.

Authors:  John P Bilello; Sabine M Lang; Fred Wang; Jon C Aster; Ronald C Desrosiers
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.